"Hyperammonemia: Monitor plasma ammonia levels during treatment. Prolonged exposure to elevated plasma ammonia levels can rapidly result in injury to the brain or death. Prompt use of all therapies necessary to reduce plasma ammonia levels is essential. (5.1) Therapeutic Monitoring: Plasma ammonia levels should be maintained within normal range for age via individual dose adjustment. (5.2) Nutritional Management: In the initial treatment of NAGS deficiency, protein restriction is recommended. When plasma ammonia level is normalized, dietary protein intake can usually be reintroduced.(5.3)",$$
"No drug interactions have been identified. (7)",$$
"The most common adverse reactions in =13% of patients are: Infections, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, and headache. ( 6.1) To report SUSPECTED ADVERSE REACTIONS, contact Recordati Rare Diseases, Inc. at 1-888-575-8344,or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.",$$
